Literature DB >> 9788598

Inhibition by phenyl N-tert-butyl nitrone of early phase carcinogenesis in the livers of rats fed a choline-deficient, L-amino acid-defined diet.

D Nakae1, Y Kotake, H Kishida, K L Hensley, A Denda, Y Kobayashi, W Kitayama, T Tsujiuchi, H Sang, C A Stewart, T Tabatabaie, R A Floyd, Y Konishi.   

Abstract

Male Wistar rats were fed a choline-deficient, L-amino acid-defined (CDAA) diet alone or in combination with a nitrone-based free radical trapping agent, phenyl N-tert-butyl nitrone (PBN) in the drinking water at the concentrations of 0.013, 0.065, and 0.130% for 12 weeks. PBN inhibited the changes that are normally induced in the livers of rats by the CDAA diet feeding, i.e., development of putative preneoplastic lesions, proliferation of connective tissue, reduction of glutathione S-transferase activity, formation of 8-hydroxyguanine in DNA, and an increase in inducible cyclo-oxygenase (COX2) activity. PBN, however, did not prevent the increases in the COX2 mRNA or protein levels brought on by the CDAA diet These results indicate that the loss of glutathione S-transferase activity and COX2 induction may play significant roles in rat liver carcinogenesis by the CDAA diet and that PBN prevents neoplasia not only by its radical scavenging activity but also by inhibiting COX2 activity at the catalytic level.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9788598

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

Review 1.  Nitrones as therapeutics.

Authors:  Robert A Floyd; Richard D Kopke; Chul-Hee Choi; Steven B Foster; Sabrina Doblas; Rheal A Towner
Journal:  Free Radic Biol Med       Date:  2008-08-29       Impact factor: 7.376

Review 2.  Anti-cancer activity of nitrones and observations on mechanism of action.

Authors:  Robert A Floyd; Hema K Chandru; Ting He; Rheal Towner
Journal:  Anticancer Agents Med Chem       Date:  2011-05-01       Impact factor: 2.505

3.  Anti-cancer activity of nitrones in the Apc(Min/+) model of colorectal cancer.

Authors:  Robert A Floyd; Rheal A Towner; Dee Wu; Andrew Abbott; Rebecca Cranford; Dan Branch; Wei-Xing Guo; Steven B Foster; Inna Jones; Rajib Alam; Danny Moore; Toby Allen; Mark Huycke
Journal:  Free Radic Res       Date:  2010-01

Review 4.  Potential implication of the chemical properties and bioactivity of nitrone spin traps for therapeutics.

Authors:  Frederick A Villamena; Amlan Das; Kevin M Nash
Journal:  Future Med Chem       Date:  2012-06       Impact factor: 3.808

Review 5.  Translational research involving oxidative stress and diseases of aging.

Authors:  Robert A Floyd; Rheal A Towner; Ting He; Kenneth Hensley; Kirk R Maples
Journal:  Free Radic Biol Med       Date:  2011-04-14       Impact factor: 7.376

6.  Reactive oxygen species in choline deficiency induced carcinogenesis and nitrone inhibition.

Authors:  Robert A Floyd; Yashige Kotake; Kenneth Hensley; Dai Nakae; Yoichi Konishi
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

Review 7.  Serendipitous findings while researching oxygen free radicals.

Authors:  Robert A Floyd
Journal:  Free Radic Biol Med       Date:  2009-02-12       Impact factor: 7.376

8.  No Modifying Effect of Antioxidant N-Acetyl-L-Cysteine on Fenofibrate-induced Hepatocarcinogenesis in Rats.

Authors:  Jihei Nishimura; Yasuaki Dewa; Meilan Jin; Yukie Saegusa; Masaomi Kawai; Sayaka Kemmochi; Keisuke Shimamoto; Tomoaki Harada; Tadashi Itoh; Tomomi Shima; Makoto Shibutani; Kunitoshi Mitsumori
Journal:  J Toxicol Pathol       Date:  2009-12-21       Impact factor: 1.628

9.  LINE-1 hypomethylation in a choline-deficiency-induced liver cancer in rats: dependence on feeding period.

Authors:  Kiyoshi Asada; Yashige Kotake; Rumiko Asada; Deborah Saunders; Robert H Broyles; Rheal A Towner; Hiroshi Fukui; Robert A Floyd
Journal:  J Biomed Biotechnol       Date:  2006

10.  Increased uracil misincorporation in lymphocytes from folate-deficient rats.

Authors:  S J Duthie; G Grant; S Narayanan
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.